KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intuitive Surgical (ISRG) Raw Materials (2016 - 2025)

Intuitive Surgical (ISRG) has 17 years of Raw Materials data on record, last reported at $531.2 million in Q3 2025.

  • For Q3 2025, Raw Materials rose 1.65% year-over-year to $531.2 million; the TTM value through Sep 2025 reached $531.2 million, up 1.65%, while the annual FY2024 figure was $563.9 million, 24.02% up from the prior year.
  • Raw Materials reached $531.2 million in Q3 2025 per ISRG's latest filing, up from $525.4 million in the prior quarter.
  • Across five years, Raw Materials topped out at $563.9 million in Q4 2024 and bottomed at $167.9 million in Q1 2021.
  • Average Raw Materials over 5 years is $385.7 million, with a median of $390.2 million recorded in 2023.
  • Peak YoY movement for Raw Materials: fell 24.78% in 2021, then soared 93.88% in 2022.
  • A 5-year view of Raw Materials shows it stood at $214.6 million in 2021, then skyrocketed by 78.42% to $382.9 million in 2022, then increased by 18.75% to $454.7 million in 2023, then increased by 24.02% to $563.9 million in 2024, then fell by 5.8% to $531.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Raw Materials were $531.2 million in Q3 2025, $525.4 million in Q2 2025, and $549.7 million in Q1 2025.